TUSTIN, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that senior management will present at the Rodman & Renshaw 10th Annual Healthcare Conference on Tuesday, November 11, 2008 at 2:00 pm ET. The conference will be held at the New York Palace Hotel in New York City.
For more information about this conference, please visit: http://www.rodmanandrenshaw.com/conferences?id=19
About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a
portfolio of innovative product candidates in clinical trials for the
treatment of cancer and serious virus infections. The company is pursuing
three separate clinical programs in cancer and HCV infection with its lead
product candidates bavituximab and Cotara(R). Peregrine also has in-house
manufacturing capabilities through its wholly owned subsidiary Avid
Bioservices, Inc. (http://www.avidbio.com), which provides development and
bio-manufacturing services for both Peregrine and outside customers.
Additional information about Peregrine can be found at
GendeLLindheim BioCom Partners
email@example.com Barbara Lindheim
(800) 987-8256 (212) 918-4650
|SOURCE Peregrine Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved